PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Senna - Constipation
PAD Profile : Senna - Constipation
Keywords :
stimulant laxatives
Brand Names Include :
Senokot
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Methylnaltrexone bromide
- Ispaghula husk
- Bisacodyl
- Glycerol
- Lactulose
- Phosphates (Rectal)
- Co-danthrusate (Dantron/docusate sodium)
- Co-danthramer (Dantron/poloxamer 188)
- Sodium citrate (Rectal)
- Naldemedine
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 October 2022
Committee Recommendations
Date
Committee Name
Narrative
02 December 2020
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have reviewed and approved the updated prescribing guidance for the treatment of constipation in adults in primary care - see guidance document below
Associated BNF Codes
01. Gastro-Intestinal System
01.06.02. Stimulant laxatives